Quarterly Results: Suven Life Science Ltd.
Bhagyashree Vivarekar / 24 Nov 2016
Suven Life Sciences Ltd is currently trading at Rs 179.4, up by 3.5 points or 1.99% from its previous close of Rs 175.90 on the BSE. The net profit increased 5.2% YoY to Rs 26.55 crore. This was led by higher effective tax rate of 32% (previously 19%).
Standalone Results Q2FY17:
Suven Life Science Ltd.’s standalone Q2FY17 results came in below Bloomberg estimates. The company's revenue was 14.3% lower than estimated Rs 135 crore. Also, net profit was 13.8% lower than the estimated Rs 31 crore. It's revenue for the quarter decreased 1.2% YoY to Rs 115.54 crore. This was led by 29% YoY dropped in services (DDDSS) segment.
The company's EBITDA increased 18.2% YoY to Rs 36.87 crore and EBITDA margin expanded by 523 bps to 31.9%. This was primarily driven by 34% YoY decline in cost of materials consumed.
The net profit increased 5.2% YoY to Rs 26.55 crore. This was led by higher effective tax rate of 32% (previously 19%).
Technical View:
Suven Life Sciences Ltd is currently trading at Rs 179.4, up by 3.5 points or 1.99% from its previous close of Rs 175.90 on the BSE.
The scrip opened at Rs 176.90 and has touched a high and low of Rs 181 and Rs 174.45, respectively. A total of 343912 (NSE+BSE) shares were traded on the counter. The stock is currently trading above its 200 DMA,
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.